Bruce Wendel
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Philip LoScalzo, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Bruce Wendel:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GT Biopharma, Inc. | Director | Option to purchase Common Stock | 500,000 | 27 Jan 2023 | Direct | ||
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 146,020 | 12 Dec 2025 | Direct |
Insider Reports Filed by Bruce Wendel
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 12 Dec 2025 | 1 | $0 | 4 | Director | 16 Dec 2025, 17:55 |
| IBRX | ImmunityBio, Inc. | 12 Dec 2025 | 0 | $0 | 3 | Director | 16 Dec 2025, 17:54 |
| GTBP | GT Biopharma, Inc. | 27 Jan 2023 | 1 | $0 | 4 | Director | 01 Feb 2023, 05:01 |
| GTBP | GT Biopharma, Inc. | 15 Jul 2022 | 2 | $0 | 4 | Director | 19 Jul 2022, 21:42 |
| GTBP | GT Biopharma, Inc. | 16 Nov 2020 | 5 | +$26,299 | 4 | Director | 07 Oct 2021, 14:47 |
| GTBP | GT Biopharma, Inc. | 11 Nov 2020 | 0 | $0 | 3 | Director | 07 Oct 2021, 14:40 |